Thermo Fisher Scientific has put forward a DNA-based test it says can offer much more precise identification of blood and its potential compatibility—going much further than the traditional positive ...

July 28 (Reuters) - Thermo Fisher Scientific Inc (TMO.N), opens new tab on Wednesday raised its full-year revenue outlook, but cut its COVID-19 test sales forecast by $900 million, citing slowing ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most undervalued large cap stocks to buy according to analysts. On July 3, Thermo Fisher Scientific announced that its Oncomine Dx Express Test, ...